Table 2 |
|||||
|
Peritumoral pathological findings The number of the mice in each experimental group is specified by n. CGA is the control group and TG1-A, TG2-A and TG3-A are the experimental subgroups of the group treated with 77 C/cm3at 1, 2 and 4 days after DEC treatment, respectively. Mc Nemar Test shows statistically significant differences in peritumoral findings at 1, 2 and 4 days. |
|||||
|
Alterations found |
Experimental Groups |
Number of mice (% of the total) in different degrees of alterationb |
|||
|
|
|||||
|
- |
+ |
++ |
+++ |
||
|
|
|||||
|
Lymphoplasmocytic infiltrate: Lymphocytes (L) and plasmatic cells (CP) |
CGA (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0) |
0 (0.0) |
|
TGA-1 day (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0) |
0 (0.0) |
|
|
TGA-2 days (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0) |
0 (0.0) |
|
|
TGA-4 days (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0) |
0 (0.0) |
|
|
Neutrophilic infiltrate (N) |
CGA (n = 6) |
6 (100.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
TGA-1 day(n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
TGA-2 days (n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
TGA-4 days (n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
Monocytic infiltrate (M) |
CGA (n = 6) |
6 (100.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
TGA-1 day (n = 6) |
0 (0.0) |
6 (100.0)a |
0 (0.0) |
0 (0.0) |
|
|
TGA-2 days (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
0 (0.0) |
|
|
TGA-4 days (n = 6) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
0 (0.0) |
|
|
Vascular congestion (CV) |
CGA (n = 6) |
6 (100.0) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
|
TGA-1 day (n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
TGA-2 days (n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
TGA-4 days (n = 6) |
0 (0.0) |
0 (0.0) |
0 (0.0) |
6 (100.0)a |
|
|
|
|||||
|
a P = 0.008. b Note: The signs " -, +, ++ and +++ ", represent: none, slight, moderate and severe intensity grades of alterations found, respectively. |
|||||
|
Ciria et al. BMC Cancer 2004 4:87 doi:10.1186/1471-2407-4-87 |
|||||
